Euro-Med Laboratories Phil., Inc.

EURO

PHY2352T1098

Pharmaceuticals

End-of-day quote Philippines S.E. Other stock markets 03:30:00 28/05/2024 am IST			5-day change	1st Jan Change
0.76 ^PHP	0.00%		+2.70%	+1.33%

13/05	Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
15/04	Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Euro-Med Laboratories Philippines Inc. Announces Appointment of Executives

March 28, 2012

Euro-Med Laboratories Philippines Inc. announced that the board at its regular meeting held on March 27, 2012, Appointed Dr. William G. Padolina as independent director and chairman of audit committee for year 2012-2013. Mr. Edwin D. Feist as independent director and Dr. Enrique C. Yap as director.

Latest news about Euro-Med Laboratories Phil., Inc.

Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/04	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11	CI
Euro-Med Laboratories Phil., Inc. Declares Cash Dividend, Payable on 27 November 2023	25/23/25	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	18/23/18	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14	CI
Euro-Med Laboratories Phil., Inc. Approves Cash Dividend, Payable on 21 November 2022	19/22/19	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15/22/15	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/22/16	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	10/22/10	CI
Euro-Med Laboratories Phil., Inc. Approves Declaration of Cash Dividend as of 31 December 2020, Paid on 24 January 2022	21/21/21	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12/21/12	CI
Euro-Med Laboratories Phil., Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2021	12/21/12	CI
Euro-Med Laboratories Phil., Inc. Appoints Mr. Anthony Joseph Y. Gaw as Director	16/21/16	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	30/21/30	CI
Euro-Med Laboratories Phil., Inc. Announces Demise of Atty. Francis Y. Gaw, Member of the Board of Directors	23/21/23	CI
Euro-Med Laboratories Phil., Inc. Announces Resignation of Michael Vincent Y. Yap as Vice President	31/21/31	CI
Euro-Med Laboratories Phil., Inc. Elects Mr. Enrique Y. Yap, Jr. as Director	18/20/18	CI
Euro-Med Laboratories Phil., Inc. Declares Cash Dividend, Payable on 08 September 2020	29/20/29	CI
Euro-Med Laboratories Phil., Inc. Provides Earnings Guidance for the Year 2020	30/20/30	CI
Euro-Med Laboratories Phil., Inc. Announces Parent Earnings Results for the First Quarter Ended March 31, 2020	30/20/30	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	29/20/29	CI
Euro-Med Laboratories Phil., Inc. Approves Resignation of Michael Vincent Y. Yap as Director and Assistant Corporate Secretary and Retirement of Rnold D. Ong as Senior Vice President	27/19/27	CI

Chart Euro-Med Laboratories Phil., Inc.

Duration

Period

More charts

Company Profile

Euro-Med Laboratories Phil., Inc. is a Philippines-based company, which is engaged in the manufacturing of pharmaceutical products, such as large and small-volume parenteral and other solutions, inhalation, irrigation, and dialysis. It also manufactures sterile water for injection, and other solutions, such as ophthalmic, inhalation, irrigation and dialysis. The Company's segments include manufacturing pharmaceutical products, providing health and other care services, and development and operation of quick service restaurants. Its subsidiaries include Hemotek Renal Center, Inc. (Hemotek), and CafeFrance Corp (CafeFrance). Hemotek provides renal and other healthcare services and is engaged as a dialysis center. CafeFrance is engaged in the development and operation of quick service restaurant (QSR). CafeFrance is engaged in operating restaurants, bakeries, food services, catering, food production and other related services incidental thereto.

Sector

Pharmaceuticals

Calendar

19/06/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
EURO-MED LABORATORIES PHIL., INC.	+1.33%	5.38Cr
SUN PHARMACEUTICAL INDUSTRIES LTD.	+16.31%	4.23TCr
OTSUKA HOLDINGS CO., LTD.	+16.32%	2.13TCr
SANDOZ GROUP AG	+19.33%	1.53TCr
CIPLA LIMITED	+18.71%	1.44TCr
ZYDUS LIFESCIENCES LIMITED	+52.78%	1.28TCr
THE MEDICINES COMPANY	-0.05%	678.76Cr
ONO PHARMACEUTICAL CO., LTD.	-12.24%	658.31Cr
STADA ARZNEIMITTEL	-8.87%	572.55Cr
ASPEN PHARMACARE HOLDINGS LIMITED	+11.64%	550.82Cr